Research has shown that ionizing radiation (measured by the radon exposure inside one’s home) is linked to having high blood pressure in non-pregnant people. Researchers in this study want to extend this finding into pregnant populations – asking if there could be a link between radon exposure and risk for developing a hypertensive disorder of pregnancy (including preeclampsia). To answer this question, researchers used medical record data from over 975,000 women from the Massachusetts Birth Registry and matched them to an average radon level from the zip code each pregnant woman lived in when she was pregnant (this let them estimate each woman’s radon exposure). Out of the 975,000 women, 36,000 developed a hypertensive disorder of pregnancy, and researchers found that higher radon levels in homes did indeed increase odds of having a hypertensive disorder of pregnancy. As we learn more about what increases risks for preeclampsia, it is incredibly important that we continue the search for risk factors that we can change – called “modifiable risk factors”. While it is certainly helpful to understand our risks for things we can’t change, like genetics or having had preeclampsia before, understanding the risk factors that we can change is a powerful step to stopping preeclampsia. As 1 in 15 homes in the United States is estimated to have elevated radon levels, this study is an excellent example of a potential modifiable risk factor that could lower a woman’s odds of developing preeclampsia. The next step for this research could be to apply what they learned to an intervention and lower radon levels in high level homes to see if it can lower the risk for preeclampsia.
Link: https://pubmed.ncbi.nlm.nih.gov/33395935/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Placental dysfunction can result in conditions such as preeclampsia, which have traditionally been managed with close monitoring and appropriately timed delivery. There is currently no cure for preecl...
Gestational hypertension continues to be a growing public health concern contributing to maternal morbidity, mortality, and long-term health complications in the U.S. While changes in vision—suc...
Background Low-dose aspirin (81 mg) is a treatment known to help lower the risk of preeclampsia. However, not everyone who is at higher risk is told to take it. This study looks at whether a screening...
Women who experienced Preeclampsia have a higher lifetime risk of developing cardiovascular disease (CVD) than women who did not suffer from this pregnancy complication. Researchers wanted to know if...
Preeclampsia Foundation and Preeclampsia Foundation Canada announced that applications are now being accepted for the 2026 Vision Grant research funding program. Three of the four grants focus on heal...
